LiCl treatment of female NZB/W mice leads to alterations in gene expression in renal tissue

Journal of Trace and Microprobe Techniques

Volumn 15, Issue 1, 1997, Pages 117-125

  Lenz, Steven P ^a   Hart, David A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Li and murine SLE; Renal gene expression and Li; Renal gene expression in SLE; Renal TNF expression; Renal urokinase expression

Indexed keywords

EID: 1842300141     PISSN: 07334680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bayaert R, Fiers W (1992) Potentiation of tumor necrosis factor-mediated activities by lithium salts: a review. Lithium 3, 181-189.
2. Brown PAJ, Wilson HM, Reid FJ, Booth NA, Simpson JG, Morrison L, Power DA, Haites NE (1994) Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int. 45, 43-47.
3. Chomczynski P (1992) Solubilization in formamide protects RNA from degradation. Nuc. Acids Res. 20, 3791-3792.
4. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Done S, Lenz SP, Benediktsson H, Fritzler MJ, Martin L, Krause G, Zhao P, Hart DA (1994) The effect of lithium on murine models of lupus nephritis. Lab. Invest. 7, 156A
6. Hart DA (1991) Immunoregulation in patients receiving lithium for affective disorders. In: Lithium and the Blood, V Gallicchio ed., Karger, Basel, pp.68-78.
7. Hart DA (1992) Regulation of plasminogen activators in connective tissues: potential for thrombolytic therapy in collagen-vascular diseases. Fibrinolysis 6 (suppl), 43-48.
8. Hart DA, Done S, Benediktsson H, Lenz SP (1994) Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride. Int. J. Immunopharmacol. 16, 825-833.
9. Hart DA, Lenz SP (1993) Lithium chloride treatment of BxSB male mice decreases survival in this murine model of SLE: potential role for gender-dependent variables. Lithium 4, 139-141.
10. Hart DA, Zhao P, Lenz SP, Martin L, Fritzler MJ, Done S, Benediktsson H, Krause G (1993) Lithium treatment of MRL-Ipr mice alters disease progression in this murine model of systemic lupus erythematosus. Lithium 4, 61-68.
11. Hart DA, Lenz SP (1996) Influence of gender and timing of initiation of treatment on LiCl enhancement of NZB/W survival. J. Trace Microprobe Techniques (in press).
12. Izui S, McConahey PJ, Clark JP, Hang LM, Hara I, Dixon FJ (1981) Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis. J. Exp. Med. 154, 517-528.
13. Jacob CO, McDevitt HO (1988) Tumor necrosis factor-a in murine autoimmune « lupus » nephritis. Nature 331, 356-358.
14. Krause G, Zhao P, Martin L, Fritzler MJ, Benediktsson H, Hart DA (1992) LiCl prolongs survival and alters disease progression in the NZB/W model of systemic lupus erythematosus. Lithium 3, 61-67.
15. Lenz SP, Izui S, Benediktsson H, Hart DA (1995) LiCl enhances survival of NZB/W mice: influence of melatonin and timing of treatment. Int. J. Immunopharmacol. 17, 581-592.
16. Lenz SP, Izui S, Hart DA (1996) Evidence that lithium chloride treatment of female NZB/W mice does not influence autoantibody profiles in this murine model of systemic lupus erythematosus. J. Trace Microprobe Techniques (in press).
17. Maniatis T, Fritsch EF, Sambrook J (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 2nd Edition, pp.
18. Reeves WH, Lahita RG (1987) Clinical presentation of systemic lupus erythematosus in the adult. In: Systemic Lupus Erythematosus, RG Lahita ed., John Wiley and sons, New York, pp.3 52-3 82.
19. Shigemoto H, Kubo S, Itoh Y, Tate G, Handa S, Maruyama N (1992) Expression and structure of serum gp70 as an acute phase protein in NZB mice. Mol. Immunol. 5, 573-582.